Form 4: Guardant Health Executive Darya Chudova Reports Stock Option and Restricted Stock Unit Awards

Sentiment:

SEC Form 4 Filing


Darya Chudova, Chief Technology Officer of Guardant Health, reports the acquisition of stock options and restricted stock units.

Summary

  • Darya Chudova, Chief Technology Officer of Guardant Health, filed a Form 4 on March 13, 2025.
  • The filing reports the grant of stock options and restricted stock units on March 12, 2025.
  • Chudova was granted options to buy 30,453 shares of common stock at an exercise price of $43.10.
  • These options vest over a three-year period, with 33% vesting on April 1, 2026, and the remaining 67% vesting in equal monthly installments over the subsequent two years.
  • Chudova also received 20,302 restricted stock units (RSUs).
  • These RSUs also vest over a three-year period, with 33% vesting on April 1, 2026, and the remaining 67% vesting in equal quarterly installments over the subsequent two years.
  • Following these transactions, Chudova directly owns 30,453 stock options and 20,302 restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of equity-based compensation is a standard practice and generally viewed favorably as it aligns management's interests with shareholders.

Positives

  • The grant of stock options and RSUs to the Chief Technology Officer aligns her interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with company performance.

Comparison to Industry Standards

  • Executive compensation packages, including stock options and RSUs, are standard practice among publicly traded companies, particularly in the tech and biotech sectors.
  • Companies like Illumina, Roche, and Exact Sciences also utilize similar equity-based compensation to incentivize their executives.
  • The vesting schedules (3 years with a cliff) are also typical in the industry.

Key Dates

DateDescription
03/12/2025Date of stock option and restricted stock unit awards
03/13/2025Date of Form 4 filing
04/01/2026First vesting date for 33% of stock options and restricted stock units
03/12/2035Expiration date of stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.